Dhanvantri Jeevan Rekha Valuation

Is 531043 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 531043 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 531043 (₹19.8) is trading below our estimate of fair value (₹123.69)

Significantly Below Fair Value: 531043 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 531043?

Key metric: As 531043 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 531043. This is calculated by dividing 531043's market cap by their current earnings.
What is 531043's PE Ratio?
PE Ratio	13.6x
Earnings	₹5.95m
Market Cap	₹81.15m

531043 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.3x
Enterprise Value/EBITDA	4.1x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 531043's PE Ratio compare to its peers?

The above table shows the PE ratio for 531043 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	21.9x
544231 Broach Lifecare Hospital	15.6x	n/a	₹142.7m
544013 KK Shah Hospitals	41.4x	n/a	₹306.4m
539428 Tejnaksh Healthcare	21.1x	n/a	₹475.3m
530897 N G Industries	9.4x	n/a	₹547.0m
531043 Dhanvantri Jeevan Rekha	13.6x	n/a	₹81.1m

Price-To-Earnings vs Peers: 531043 is good value based on its Price-To-Earnings Ratio (13.6x) compared to the peer average (21.9x).

Price to Earnings Ratio vs Industry

How does 531043's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap
523696 Fortis Malar Hospitals	2.1x	n/a	US$11.76m
542918 Gian Life Care	4.9x	n/a	US$2.33m

No more companies available in this PE range

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 531043 is good value based on its Price-To-Earnings Ratio (13.6x) compared to the Indian Healthcare industry average (41.9x).

Price to Earnings Ratio vs Fair Ratio

What is 531043's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

531043 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	13.6x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 531043's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Medico Intercontinental

₹592.5m

Trades in pharmaceutical products.

539938

₹59.25

28.6%

-37.0%

N G Industries

₹547.0m

Provides various healthcare services in India.

530897

₹163.25

-2.7%

-2.5%

Dr Lalchandani Labs

₹78.0m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.00

n/a